Agenzia Italiana del Farmaco Home
Data on COVID-19 vaccinations
Asset Publisher
22/02/2021
Monitoring Registers
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
18/02/2021
Research and clinical trials
L’Agenzia evidenzia le caratteristiche ritenute importanti per la produzione di evidenze a sostegno dell’efficacia nella pratica clinica e della sicurezza dei vaccini COVID-19.
17/02/2021
Transparency Lists
AIFA has published the updated Transparency Lists of generic medicines together with the related reference prices, updated at 17 February 2021.
05/02/2021
Press corner
Press Release no. 629 - AIFA publishes the opinion of its Scientific-Technical Committee (CTS), which met in extraordinary session on 2, 3 and 4 February 2021, on the use of monoclonal antibodies.
AIFA Focus
AIFA Focus
"Do you want to know more about COVID-19 vaccines?"
AIFA data
AIFA data
GMP inspections (API and medicinal products) 2019
